Drug intelligence / Profile preview

Medterra Daily Relief Pet CBD Tincture

Development stage
Unknown
Lead developer
Medterra
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Medterra Daily Relief Pet CBD Tincture is a consumer wellness supplement developed by Medterra for use in dogs and cats. The product features hemp-derived cannabidiol (CBD) isolate, ensuring a THC-free formulation that is standardized to 10mg of CBD per 1mL serving. It is delivered in an organic medium-chain triglyceride (MCT) oil base, which facilitates oral or sublingual absorption. The tincture is intended to support the pet's endocannabinoid system to promote calmness, manage stress-related anxiety, and support joint health and mobility. As a non-pharmaceutical consumer product, it is third-party lab tested and adheres to U.S. Hemp Authority certification standards, offering various flavors like beef and chicken to enhance compliance in domestic animals.

Brand names
Medterra Daily Relief Pet CBD Tincture
Other names
Medterra CBD Pet TinctureMedterra Pet CBD Oil
02

Targets

CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on Medterra Daily Relief Pet CBD Tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medterra Daily Relief Pet CBD Tincture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call